0
0

Chapter 58. Treatment of Substance-Related Disorders

Charles P. O'Brien, M.D., Ph.D.; Charles A. Dackis, M.D.
DOI: 10.1176/appi.books.9781585623860.434964

Sections

Excerpt

Drugs that produce substance use disorders all activate the brain reward system, but each class of drugs activates the system by a different pharmacological mechanism. Thus, this chapter is organized according to pharmacological class. The emphasis is on pharmacotherapy, but all treatment using medications should be accompanied by counseling or psychotherapy according to the patient's needs. Medication combines very well with psychotherapy, including self-help groups such as Alcoholics Anonymous (AA). The majority of patients also have an additional mental disorder (besides the addictive disorder) such as depression, anxiety, or bipolar disorder. These comorbidities require specific treatment including medication and psychotherapy. The best treatments for addiction complicated by additional psychiatric disorders are delivered in an integrated fashion, preferably from the same therapist. All psychiatrists should be able to manage substance use disorders, especially those that co-occur with other psychiatric diagnoses.

Your session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

+

CME Activity

Add a subscription to complete this activity and earn CME credit.
Sample questions:
1.
Among medications approved by the U.S. Food and Drug Administration (FDA) to treat alcohol dependence, which of the following has effects on the -aminobutyric acid (GABA)/N-methyl-d-aspartate (NMDA) complex?
2.
A patient who has been a pack-a-day smoker for over 20 years now wishes to quit. You initially recommend nicotine replacement therapy in the form of a nicotine patch. Research findings suggest that what percentage of patients treated with transdermal nicotine will be able to stop smoking and remain abstinent after 1 year?
3.
Which of the following statements concerning benzodiazepines is true?
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Related Content
Articles
Books
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 19.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 23.  >
DSM-IV-TR® Diagnostic and Statistical Manual of Mental Disorders > Chapter 4.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 17.  >
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 1.  >
Topic Collections
Psychiatric News
PubMed Articles
 
  • Print
  • PDF
  • E-mail
  • Chapter Alerts
  • Get Citation